About the Blood Cancer Session
Hematologic malignancies, collectively known as blood cancer, encompass a spectrum of diseases affecting the blood, bone marrow, and lymphatic system. This intricate field of cancer research delves into unraveling the underlying mechanisms driving these diseases, revolutionizing diagnostic techniques, and pioneering tailored therapeutic interventions. Breakthroughs in genomic analysis have unveiled pivotal genetic aberrations fueling blood cancers, paving the way for precision medicine approaches. Immunotherapies, such as CAR-T cell therapy, present promising avenues by leveraging the body's immune prowess against malignant cells. Beyond conventional treatments, ongoing clinical investigations explore innovative strategies, including targeted pharmacotherapies and stem cell transplants. Through synergistic collaborations across disciplines, researchers forge ahead in their quest for transformative advancements, offering renewed hope for individuals grappling with blood cancer.
Topics Covered in Blood Cancer
Acute & Chronic Leukemias
Lymphoma Subtypes
Multiple Myeloma
Myelodysplastic Syndromes
CAR-T Cell Therapy
Stem Cell Transplant
Related Scientific Sessions at CIOC 2027
Why Attend the Blood Cancer Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Blood Cancer work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Blood Cancer research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Blood Cancer track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Blood Cancer Conference 2027 — FAQs
What is the Blood Cancer track at CIOC 2027?
The Blood Cancer track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Blood Cancer. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Blood Cancer sessions?
Cancer researchers and clinicians, educators and students with an interest in Blood Cancer are all welcome — whether presenting or attending.
Can I present my research in the Blood Cancer track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Blood Cancer sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Blood Cancer track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.